Development and pharmacokinetic evaluation of Neusilin® US2-based S-SNEDDS tablets for bosentan: Fasted and fed states bioavailability, IVIS® real-time biodistribution, and ex-vivo imaging
- 9 July 2023
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 643, 123219
Abstract
No abstract availableKeywords
Funding Information
- Türkiye Bilimsel ve Teknolojik Araştırma Kurumu (217S602)
- Gazi Üniversitesi
This publication has 79 references indexed in Scilit:
- Incomplete Desorption of Liquid Excipients Reduces the in Vitro and in Vivo Performance of Self-Emulsifying Drug Delivery Systems Solidified by Adsorption onto an Inorganic Mesoporous CarrierMolecular Pharmaceutics, 2012
- In vivo imaging of drug delivery systems in the gastrointestinal tractInternational Journal of Pharmaceutics, 2011
- In vitro lipolysis models as a tool for the characterization of oral lipid and surfactant based drug delivery systemsInternational Journal of Pharmaceutics, 2011
- DDSolver: An Add-In Program for Modeling and Comparison of Drug Dissolution ProfilesThe AAPS Journal, 2010
- Design of Lipid-Based Formulations for Oral Administration of Poorly Water-Soluble Drugs: Precipitation of Drug after Dispersion of Formulations in Aqueous SolutionJournal of Pharmaceutical Sciences, 2009
- Evaluation of the Impact of Surfactant Digestion on the Bioavailability of Danazol after Oral Administration of Lipidic Self-Emulsifying Formulations to DogsJournal of Pharmaceutical Sciences, 2008
- The effect of different lipid based formulations on the oral absorption of lipophilic drugs: The ability of in vitro lipolysis and consecutive ex vivo intestinal permeability data to predict in vivo bioavailability in ratsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2007
- In vivo imaging in experimental preclinical tumor research–A reviewCytometry Part A, 2007
- Effect of adsorbents on the absorption of lansoprazole with surfactantInternational Journal of Pharmaceutics, 2005
- Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled studyThe Lancet, 2001